Marin B, Boumédiene F, Logroscino G, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74. https://doi.org/10.1093/ije/dyw061.
Marin B, Logroscino G, Boumédiene F, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31:229–45. https://doi.org/10.1007/s10654-015-0090-x.
Renton AE, Chiò A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17–23. https://doi.org/10.1038/nn.3584.
CAS Article PubMed Google Scholar
Bozzoni V, Pansarasa O, Diamanti L, et al. Amyotrophic lateral sclerosis and environmental factors. Funct Neurol. 2016;31:7–19.
PubMed PubMed Central Google Scholar
Filippini T, Tesauro M, Fiore M, et al. Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case-control study. Int J Environ Res Pub Health. 2020. https://doi.org/10.3390/ijerph17082882.
Jacquez GM, Waller LA, Grimson R, Wartenberg D. The analysis of disease clusters, Part I: state of the art. Infect Control Hosp Epidemiol. 1996;17:319–27. https://doi.org/10.1086/647301.
CAS Article PubMed Google Scholar
Longinetti E, Pupillo E, Belometti C, et al. Geographical clusters of amyotrophic lateral sclerosis and the bradford hill criteria. Amyotroph Later Scler Front Degener. 2021;23(5–6):329–43.
Olsen SF, Martuzzi M, Elliott P. Cluster analysis and disease mapping–why, when, and how? a step by step guide. BMJ. 1996;313:863–6.
Plato CC, Garruto RM, Galasko D, et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol. 2003;157:149–57. https://doi.org/10.1093/aje/kwf175.
Murch SJ, Cox PA, Banack SA, et al. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from guam. Acta Neurol Scand. 2004;110:267–9. https://doi.org/10.1111/j.1600-0404.2004.00320.x.
CAS Article PubMed Google Scholar
Araki S, Iwahashi Y, Kuroiwa Y. Epidemiological study of amyotrophic lateral sclerosis and allied disorders in the kii peninsula (Japan). J Neurol Sci. 1967;4:279–87. https://doi.org/10.1016/0022-510x(67)90106-2.
CAS Article PubMed Google Scholar
Kihira T, Yoshida S, Kondo T, et al. An increase in ALS incidence on the Kii Peninsula, 1960–2009: a possible link to change in drinking water source. Amyotroph Later Scler. 2012;13:347–50. https://doi.org/10.3109/17482968.2012.674140.
Migliaretti G, Berchialla P, Dalmasso P, et al. Amyotrophic lateral sclerosis in piedmont (Italy): a Bayesian spatial analysis of the incident cases. Amyotroph Later Scler Front Degener. 2013;14:58–65. https://doi.org/10.3109/21678421.2012.733401.
Lannuzel A, Mecharles S, Tressières B, et al. Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the caribbean island of guadeloupe: a new focus of ALS associated with parkinsonism. Amyotroph Later Scler Front Degener. 2015;16:216–23. https://doi.org/10.3109/21678421.2014.992026.
De Benedetti S, Lucchini G, Del Bò C, et al. Blood trace metals in a sporadic amyotrophic lateral sclerosis geographical cluster. Biometals Int J Role Met Ions Biol Biochem Med. 2017;30:355–65. https://doi.org/10.1007/s10534-017-0011-4.
Kilness AW, Hichberg FH. Amyotrophic lateral sclerosis in a high selenium environment. JAMA. 1977;237:2843–4.
Masseret E, Banack S, Boumédiène F, et al. Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern France. PLoS ONE. 2013;8: e83406. https://doi.org/10.1371/journal.pone.0083406.
CAS Article PubMed PubMed Central Google Scholar
Banack SA, Metcalf JS, Bradley WG, Cox PA. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida. Toxicon Off J Int Soc Toxinol. 2014;90:167–73. https://doi.org/10.1016/j.toxicon.2014.07.018.
Delzor A, Couratier P, Boumédiène F, et al. Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme. BMJ Open. 2014;4: e005528. https://doi.org/10.1136/bmjopen-2014-005528.
Article PubMed PubMed Central Google Scholar
Delzor A, Marin B, Boumediene F, et al. BMAALS: a French national project searching for a link between amyotrophic lateral sclerosis and the neurotoxic amino acid L-BMAA. Amyotroph Later Scler Front Degener. 2014;15:155–6. https://doi.org/10.3109/21678421.2013.837933.
Marin B, Hamidou B, Couratier P, et al. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe–the French register of ALS in Limousin (FRALim register). Eur J Neurol. 2014;21(1292–1300):e78-79. https://doi.org/10.1111/ene.12474.
Brooks BR, Miller RG, Swash M, et al. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Later Scler Mot Neuron Disord. 2000;1:293–9. https://doi.org/10.1080/146608200300079536.
Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev. 1995;17:243–64. https://doi.org/10.1093/oxfordjournals.epirev.a036192.
CAS Article PubMed Google Scholar
Orton H, Rickard R, Gabella B. Capture-recapture estimation using statistical software. Epidemiol Camb Mass. 1999;10:563–4. https://doi.org/10.1097/00001648-199909000-00021.
Sakamoto Y, Ishiguro M, Kitagawa G. Akaike Information Criterion Statistics. Netherlands: Springer; 1986.
Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6:461–4. https://doi.org/10.1214/aos/1176344136.
Germonneau P, Thillaut H, Santo GDE, E, Borraz O,. Aspects méthodologiques de l’investigation des signalements d’agrégats spatio-temporels de maladies non infectieuses. Environ Risques Santé. 2005;4:329–34.
Breslow NE, Day NE (1987) Statistical methods in cancer research. volume II--the design and analysis of cohort studies. IARC Sci Publ: 1–406
Potthoff RF (2014) Homogeneity, Potthoff-Whittinghill Tests of. In: Wiley StatsRef: Stat Refer Online American Cancer Soc
Anselin L. Local Indicators of spatial association—ISA. Geogr Anal. 2010;27:93–115. https://doi.org/10.1111/j.1538-4632.1995.tb00338.x.
Kulldorff M, Nagarwalla N. Spatial disease clusters: detection and inference. Stat Med. 1995;14:799–810. https://doi.org/10.1002/sim.4780140809.
CAS Article PubMed Google Scholar
Blum A, Biraben J-N. Cliff A.D. et Ord J.K. — spatial processes. Mode appl Popul. 1982;37:963–963.
Lagrange E, Bonneterre V, Talbot K, et al (2017) A high-incidence cluster of ALS in the French Alps: common environment and multiple exposures. In: RISE 2nd International Meeting on Environmental Health 2017, Strasbourg, France.
Lagrange E, Vernoux JP, Reis J, et al. An amyotrophic lateral sclerosis hot spot in the French alps associated with genotoxic fungi. J Neurol Sci. 2021;427: 117558. https://doi.org/10.1016/j.jns.2021.117558.
CAS Article PubMed Google Scholar
Lagrange E, Juntas-Morales R, Pageot N, et al. The cyanotoxin BMAA and increased incidence in ALS clusters: a public health concern in France. Amyotroph Later Scler Front Degener. 2018;19:180.
Nicoletti A, Vasta R, Venti V, et al. The epidemiology of amyotrophic lateral sclerosis in the Mount Etna region: a possible pathogenic role of volcanogenic metals. Eur J Neurol. 2016;23:964–72. https://doi.org/10.1111/ene.12973.
CAS Article PubMed Google Scholar
Boumediene F, Vasta R, Rascunà C, et al. Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy. Eur J Neurol. 2019;26:e90–1. https://doi.org/10.1111/ene.14011.
CAS Article PubMed Google Scholar
Luna J, Leleu J-P, Preux P-M, et al. Residential exposure to ultra high frequency electromagnetic fields emitted by Global System for Mobile (GSM) antennas and amyotrophic lateral sclerosis incidence: A geo-epidemiological population-based study. Environ Res. 2019;176: 108525. https://doi.org/10.1016/j.envres.2019.108525.
CAS Article PubMed Google Scholar
Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90. https://doi.org/10.1136/jnnp.2009.183525.
Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference. Neuroepidemiology. 2019;52:93–103. https://doi.org/10.1159/000493386.
Erazo D, Luna J, Preux P-M, et al. Amyotrophic lateral sclerosis mortality rates in latin America and the caribbean: a meta-analysis. Amyotroph Later Scler Front Degener. 2022. https://doi.org/10.1080/21678421.2022.2048310.
Logroscino G, Piccininni M, Marin B, et al. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17:1083–97. https://doi.org/10.1016/S1474-4422(18)30404-6.
Rooney J, Vajda A, Heverin M, et al. Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland. Neurology. 2015;84:1537–44. https://doi.org/10.1212/WNL.0000000000001477.
Uenal H, Rosenbohm A, Kufeldt J, et al. Incidence and geographical variation of amyotrophic lateral sclerosis (als) in southern germany – completeness of the ALS registry Swabia. PLoS ONE. 2014;9: e93932. https://doi.org/10.1371/journal.pone.0093932.
Article PubMed PubMed Central Google Scholar
Caller TA, Chipman JW, Field NC, Stommel EW. Spatial analysis of amyotrophic lateral sclerosis in northern new England, USA, 1997–2009. Muscle Nerve. 2013;48:235–41. https://doi.org/10.1002/mus.23761.
留言 (0)